总血栓形成系统探索肝硬化患者的初级血静
Johan Abdoul1, Norman Luc2, Bérangère S Joly3,4
1Université Paris-Saclay, INSERM, Hémostase Inflammation Thrombose HITh U1176, Le Kremlin-Bicêtre, France.
Research and practice in thrombosis and haemostasis
|February 27, 2026
概括
肝硬化患者表现出初级血液静止受损,正如全血栓形成分析系统 (T-TAS 01) 测试所显示的那样. 该系统有效地检测肝硬化患者的出血风险,帮助临床监测.
科学领域:
- 血液学 血液学 血液学
- 血栓形成的研究研究
- 肝病病理生理学 肝病病理生理学
背景情况:
- 在肝硬化中,由于血小板缩,血小板功能障碍,威尔布兰德因子 (VWF) 升高和ADAMTS13活性降低,原发性血液静止受损.
- 目前的测试单独评估静血参数或使用静态模型,可能缺少动态流动效应.
研究的目的:
- 通过使用全血栓形成分析系统 (T-TAS 01) 在肝硬化患者的流动条件下调查血栓形成.
- 评估合成血小板模仿纳米颗粒 (PMNPs) 在肝硬化血液样本中改善静血功能的潜力.
主要方法:
- 一项观察性研究涉及30名肝硬化患者和30名对照人群.
- 分析包括血细胞计数,VWF分析,ADAMTS13活性和T-TAS 01测定 (原涂层芯片).
- T-TAS 01还在添加PMNPs的肝硬化样本上进行,以评估疗效.
主要成果:
- 与对照组相比,肝硬化患者的血小板数量较低,VWF较高,ADAMTS13活性降低.
- 在肝硬化患者中,T-TAS 01揭示了显著延长的血栓形成时间和减少曲线下的面积.
- 血静性损伤与更高的查尔德-普格评分相关;PMNP的影响有限.
结论:
- 在肝硬化中,T-TAS 01有效检测出静血功能障碍,独立于VWF水平升高.
- 这种动态流量分析系统是肝硬化患者临床和生物监测的宝贵工具.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
01:30Venous Thrombosis I: Introduction
578
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
578
01:20Extrinsic and Intrinsic Pathways of Hemostasis
14.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.0K
01:29Venous Thrombosis III: Interprofessional Care
423
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
423
01:24Disorders of Hemostasis
2.4K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.4K
01:16Clot Retraction and Fibrinolysis
9.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.6K